Insider sale
ALPHA TAU MEDICAL LTD.
$447.7K
108.09K shares
What this filing means
GAT AMNON plans to sell 108.09K shares of ALPHA TAU MEDICAL LTD. valued at approximately $447.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/11/2025ACC: 0001976408-25-000399
108.09K
Shares to sell
$447.7K
Approx. market value
60.09K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Employee Stock Options plan
Cash Upon Exercise
2/21/2017
12.09KEmployee Stock Options plan
Cash Upon Exercise
2/21/2017
48KTotal acquired60.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/21/2017 | Employee Stock Options plan Cash Upon Exercise | 12.09K | — |
2/21/2017 | Employee Stock Options plan Cash Upon Exercise | 48K | — |
| Total | 60.09K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
16K
Market value
$61.8K
12/1/2025
—Completed
Units to sell
16K
Market value
$61.8K
11/3/2025
—Completed
Units to sell
16K
Market value
$69.9K
10/1/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
60.09K
Market value
$254.2K
12/10/2025
Total
Units
108.09K
Value
$447.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/1/2025 | 16K | $61.8K | — | Completed |
11/3/2025 | 16K | $61.8K | — | Completed |
10/1/2025 | 16K | $69.9K | — | Completed |
| Planned — Approximate Date | ||||
12/10/2025 | 60.09K | $254.2K | Nasdaq | Planned |
| Total | 108.09K | $447.7K | ||